Gerrit‐Jan de Haan

3.2k total citations
34 papers, 1.2k citations indexed

About

Gerrit‐Jan de Haan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Gerrit‐Jan de Haan has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 15 papers in Pediatrics, Perinatology and Child Health and 9 papers in Genetics. Recurrent topics in Gerrit‐Jan de Haan's work include Epilepsy research and treatment (21 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Gerrit‐Jan de Haan is often cited by papers focused on Epilepsy research and treatment (21 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Gerrit‐Jan de Haan collaborates with scholars based in Netherlands, United Kingdom and Italy. Gerrit‐Jan de Haan's co-authors include Dick Lindhout, Peter M. Edelbroek, Josemir W. Sander, Martijn Engelsman, Bobby P.C. Koeleman, Dorothée Kasteleijn‐Nolst Trenité, Paul B. Augustijn, Daniël M. Jonker, Geert J.F. Brekelmans and Bianca Berghuis and has published in prestigious journals such as Neurology, Annals of Neurology and Ophthalmology.

In The Last Decade

Gerrit‐Jan de Haan

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerrit‐Jan de Haan Netherlands 23 770 613 284 147 128 34 1.2k
Daniela Trotta Italy 18 542 0.7× 573 0.9× 143 0.5× 150 1.0× 50 0.4× 51 1.2k
Angela La Neve Italy 20 1.2k 1.6× 986 1.6× 408 1.4× 146 1.0× 115 0.9× 55 1.6k
Athanasios Gaitatzis United Kingdom 12 1.3k 1.7× 946 1.5× 271 1.0× 118 0.8× 58 0.5× 19 1.6k
Kevan VanLandingham United States 19 1.1k 1.4× 606 1.0× 727 2.6× 117 0.8× 51 0.4× 32 1.9k
Linda J. Stephen United Kingdom 28 1.9k 2.4× 1.6k 2.6× 689 2.4× 91 0.6× 125 1.0× 44 2.1k
Robert J. Baumann United States 21 557 0.7× 568 0.9× 149 0.5× 114 0.8× 37 0.3× 74 1.4k
Kore Liow United States 20 775 1.0× 586 1.0× 272 1.0× 49 0.3× 54 0.4× 63 1.2k
Kyoung Heo South Korea 22 790 1.0× 563 0.9× 362 1.3× 59 0.4× 27 0.2× 88 1.4k
P. R. Camfield Canada 20 843 1.1× 730 1.2× 232 0.8× 94 0.6× 29 0.2× 36 1.2k
Patricia K. Crumrine United States 18 766 1.0× 629 1.0× 300 1.1× 89 0.6× 37 0.3× 34 1.3k

Countries citing papers authored by Gerrit‐Jan de Haan

Since Specialization
Citations

This map shows the geographic impact of Gerrit‐Jan de Haan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit‐Jan de Haan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit‐Jan de Haan more than expected).

Fields of papers citing papers by Gerrit‐Jan de Haan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit‐Jan de Haan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit‐Jan de Haan. The network helps show where Gerrit‐Jan de Haan may publish in the future.

Co-authorship network of co-authors of Gerrit‐Jan de Haan

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit‐Jan de Haan. A scholar is included among the top collaborators of Gerrit‐Jan de Haan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit‐Jan de Haan. Gerrit‐Jan de Haan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berghuis, Bianca, Anja C. M. Sonsma, Mark McCormack, et al.. (2021). Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy. Epilepsia. 62(3). 778–784. 10 indexed citations
2.
Villanueva, Vicente, Beatriz G. Giráldez, Manuel Toledo, et al.. (2018). Lacosamide monotherapy in clinical practice: A retrospective chart review. Acta Neurologica Scandinavica. 138(3). 186–194. 22 indexed citations
3.
Berghuis, Bianca, Job van der Palen, Gerrit‐Jan de Haan, et al.. (2017). Carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy. Epilepsia. 58(7). 1227–1233. 45 indexed citations
4.
Giráldez, Beatriz G., Manuel Toledo, Gerrit‐Jan de Haan, et al.. (2017). Effectiveness of lacosamide monotherapy in clinical practice: a retrospective chart review in patients with focal seizures (P5.230). Neurology. 88(16_supplement). 1 indexed citations
5.
Berghuis, Bianca, Gerrit‐Jan de Haan, Marcel P. H. van den Broek, et al.. (2016). Epidemiology, pathophysiology and putative genetic basis of carbamazepine‐ and oxcarbazepine‐induced hyponatremia. European Journal of Neurology. 23(9). 1393–1399. 33 indexed citations
6.
Clayton, Lisa M., et al.. (2012). Patterns of Peripapillary Retinal Nerve Fiber Layer Thinning in Vigabatrin-Exposed Individuals. Ophthalmology. 119(10). 2152–2160. 24 indexed citations
7.
Clayton, Lisa M., Constantinos Kallis, Gerrit‐Jan de Haan, et al.. (2011). Retinal nerve fiber layer thickness in Vigabatrin‐exposed patients. Annals of Neurology. 69(5). 845–854. 34 indexed citations
8.
Wegner, Ilse, Peter M. Edelbroek, Gerrit‐Jan de Haan, Dick Lindhout, & Josemir W. Sander. (2010). Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Epilepsia. 51(12). 2500–2502. 36 indexed citations
9.
Haan, Gerrit‐Jan de, et al.. (2009). A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 51(3). 478–482. 75 indexed citations
10.
Krämer, Günter, Arnaud Biraben, Mar Carreño, et al.. (2007). Current approaches to the use of generic antiepileptic drugs. Epilepsy & Behavior. 11(1). 46–52. 47 indexed citations
11.
Haan, Gerrit‐Jan de, et al.. (2006). Oligogenic inheritance in photosensitive juvenile myoclonic epilepsy?. Epileptic Disorders. 8(1). 32–36. 3 indexed citations
12.
Pinto, Dalila, Linda Volkers, Gerrit‐Jan de Haan, et al.. (2006). Heterogeneity at the JME 6p11–12 Locus: Absence of Mutations in the EFHC1 Gene in Linked Dutch Families. Epilepsia. 47(10). 1743–1746. 14 indexed citations
13.
Haan, Gerrit‐Jan de, Dalila Pinto, D. Carton, et al.. (2006). A Novel Splicing Mutation in KCNQ2 in a Multigenerational Family with BFNC Followed for 25 Years. Epilepsia. 47(5). 851–859. 26 indexed citations
14.
Haan, Gerrit‐Jan de, et al.. (2005). Monozygous Twin Brothers Discordant for Photosensitive Epilepsy: First Report of Possible Visual Priming in Humans. Epilepsia. 46(9). 1545–1549. 7 indexed citations
15.
Pinto, Dalila, Gerrit‐Jan de Haan, Gabrielle Rudolf, et al.. (2004). Genome-wide linkage scan of epilepsy-related photoparoxysmal electroencephalographic response: evidence for linkage on chromosomes 7q32 and 16p13. Human Molecular Genetics. 14(1). 171–178. 76 indexed citations
16.
Pinto, Dalila, Gerrit‐Jan de Haan, Eduard H. Boezeman, et al.. (2004). Evidence for Linkage between Juvenile Myoclonic Epilepsy–Related Idiopathic Generalized Epilepsy and 6p11‐12 in Dutch Families. Epilepsia. 45(3). 211–217. 22 indexed citations
17.
Deckers, C. L. P., et al.. (2003). Selection Criteria for the Clinical Use of the Newer Antiepileptic Drugs. CNS Drugs. 17(6). 405–421. 27 indexed citations
18.
Jonker, Daniël M., et al.. (2002). Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. British Journal of Clinical Pharmacology. 53(5). 501–507. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026